Funding for this research was provided by:
ViiV Healthcare (ITCRZF51)
Medical Research Council (MR/K012126/1)
Department for International Development (MR/K012126/1)
European and Developing Countries Clinical Trials Partnership (MR/K012126/1)
Received: 5 April 2019
Accepted: 25 September 2019
First Online: 28 November 2019
Ethics approval and consent to participate
: Ethical approval for the research was given by the University of KwaZulu-Natal Biomedical Research Ethics Committee (BREC) [BE472/15], and the Ethics Committee of the London School of Hygiene and Tropical Medicine [Ref 11092]. Access to DHIS data was provided by AHRI following a formal request to their Research Data manager (Ticket#1053615, Feb 2018).
: Not applicable.
: The authors declare that they have no competing interests.